桂枝茯苓方在脑血管疾病中的应用及作用机制研究进展  

Research progress on clinical applications and mechanisms of Guizhi Fuling Prescription in treating cerebrovascular diseases

作　　者：张家明 余妮 任醒华 梁银[2] 周小毛 余尚贞 

机构地区：[1]暨南大学中医学院,广东广州510000 [2]湖南中医药大学,湖南长沙410208 [3]暨南大学附属江门中医院,广东江门529000

出　　处：《中草药》2017年第24期5276-5280,共5页Chinese Traditional and Herbal Drugs

摘　　要：脑血管病具有高发病率、高致残率、高死亡率及高再发率的特点,是现代研究重点。现代研究表明桂枝茯苓方具有抗炎、免疫调节、抗氧化等作用,可以用于缺血性脑血管病与出血性脑血管病的治疗,但临床主要运用于缺血性脑血管病,其中又以急性脑梗死为主,并且取得较好的临床疗效。对桂枝茯苓方在脑血管病的临床应用及作用机制研究进展进行综述,以期为桂枝茯苓方在脑血管病的深入研究提供参考。Cerebrovascular diseases（CVD） with high morbidity, disability, mortality, and recurrence rate have become the focus in the medical research. Modern researches have indicated that Guizhi Fuling Prescription（GFP） possesses anti-inflammatory, immune-modulation and anti-oxidative effects and so on. Investigations showed that GFP had been used in the researches of ischemic and hemorrhagic cerebrovascular diseases, mainly used in the clinical research of ischemic cerebrovascular, in which the research of treating acute cerebral infarction gets the best clinical effect of all. In order to provide theoretical reference for intensive research of GFP in treatment of CVD, this article reviewed the research progress in clinical application and mechanisms of GFP in treatment of CVD.

关 键 词：桂枝茯苓丸 脑血管病 抗炎活性 免疫调节活性 抗氧化活性 治疗机制 急性脑梗死 

分 类 号：R285[医药卫生—中药学]